| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07023315 | A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for… | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma | Recruiting |
| Phase 2 | |||
| NCT07315854 | Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated… | Gastric Cancer (GC) | Recruiting |
| NCT07474324 | Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for… | GC/GEJC | Recruiting |
| NCT07353684 | Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric… | Adebrelimab | Recruiting |
| NCT07315035 | QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer | Gastric Cancer Stage III | Not Yet Recruiting |
| NCT07507916 | Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal… | ctDNA | Not Yet Recruiting |